arrow
M

María Célica Ysrraelit

Buenos Aires
H指数:23
被引数:3,086

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study

克拉屈滨作为50岁以上多发性硬化患者治疗方案的疗效与安全性:一项真实世界研究

2025-10-140
PRE
Gender gap in medicine: a call to action for Latin America

医学领域的性别差距:拉丁美洲的行动呼吁

2025-08-300
OAAI
Additional Cladribine tablets treatment courses in multiple sclerosis patients. A retrospective observational study in Latin American countries

多发性硬化患者接受额外克拉屈滨片治疗疗程。一项在拉丁美洲国家进行的研究回顾性观察研究。

2025-02-010
PRE
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
2024-07-261
PRE
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
2024-07-010
PRE
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry

根据患者的年龄和疾病活动选择多发性硬化症的疾病修饰疗法: 来自全国注册中心的数据

2024-06-011
PRE
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
2023-07-255
PRE
Performance of McDonald 2017 multiple sclerosis diagnostic criteria and evaluation of genetic ancestry in patients with a first demyelinating event in Argentina

McDonald 2017多发性硬化症诊断标准的表现以及阿根廷首次脱髓鞘事件患者的遗传血统评估

2023-03-213
PRE
Consensus recommendations on the management of multiple sclerosis patients in Argentina
2020-02-0112
PREAI
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients (vol 385, pg 217, 2018)
2018-04-015
OAAI